Jin Medical International Ltd. (ZJYL)

Every figure this model derived for ZJYL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-09-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 6,629,800 PaymentsToAcquirePropertyPlantAndEquipment 2025-09-30
cash 29,630,237 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2025-09-30
current assets 44,143,213 AssetsCurrent 2025-09-30
current liabilities 23,795,891 LiabilitiesCurrent 2025-09-30
equity 29,638,722 StockholdersEquity 2025-09-30
interest expense 411,068 InterestPaidNet 2025-09-30
ocf 2,903,584 NetCashProvidedByUsedInOperatingActivities 2025-09-30
revenue 20,687,274 Revenues 2025-09-30

The ratios

The figures themselves rather than their scores — what somebody looking up ZJYL on one particular measure came for.

RatioValue
cash operating margin4.12
current ratio1.89
current ratio reported1.86
deferred revenue growth-26.22
dilution pct0.05
ebit cagr-30.66
ebit yoy-83.29
fcf margin-18.01
growth cv20.48
interest cover1.48
operating margin2.94
owner earnings margin-18.01
revenue growth-11.98
revenue growth per share-12.02
roic5662.51
rule of 40-9.04
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about ZJYL's figures. Written by the derivation as it ran, not added afterwards.